Key facts
- Recursion Pharmaceuticals director Christopher Gibson sold $144,800 in stock.
- The transaction involved the sale of Recursion Pharma stock.
Recursion Pharmaceuticals director Christopher Gibson has sold $144,800 worth of the company's stock. This sale follows a recent transaction by CEO Najat Khan, who sold $84,459 in stock.